Company / Current Assets per Share
Compass Therapeutics, Inc. Current Assets per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.96
FY2024
5-year range
$0.96 / $2.34
FY2020-FY2024
Trend
-20.1%
vs FY2023
Sector context
#195 of 210
Health Care
What the data says
Among 210 Health Care companies, Compass Therapeutics, Inc. is in the bottom 7% for current assets per share. Current Assets per Share has declined for 3 consecutive years, from $2.34 in FY2021 to $0.96 in FY2024.
Based on SEC 10-K filings.
0.96 in FY2024 with a 5-year CAGR of -24.5%.
Declined from $1.54 to $0.96 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -25.6%
- 5-Year CAGR
- -24.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 210This company $0.96 Sector average $170.46
▼
-99.4% below sector average
Key checks
Key Insights
- Compass Therapeutics, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2024, current assets per share decreased 20.1% year-over-year.
- Ranks #195 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.96 | -20.1% |
| FY2023 | $1.21 | -21.8% |
| FY2022 | $1.54 | -34.1% |
| FY2021 | $2.34 | +43.4% |
| FY2020 | $1.63 | -58.4% |
| FY2019 | $3.92 | +78427638.8% |
| FY2018 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026